Biological Products, (No Diagnostic Substances)
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| MPM BIOIMPACT LLC | 3.67M | $60.0M | 0.85% | -1.55M | 2026-06-30 |
| Siren, L.L.C. | 1.86M | $30.0M | 0.43% | -- | 2026-06-30 |
| Vivo Capital, LLC | 1.84M | $30.0M | 0.43% | -822.8K | 2026-06-30 |
| PERCEPTIVE ADVISORS LLC | 1.65M | $27.0M | 0.38% | +689.0K | 2026-06-30 |
| BAKER BROS. ADVISORS LP | 1.46M | $23.0M | 0.34% | -- | 2026-06-30 |
| Artisan Partners Limited Partnership | 1.37M | $22.0M | 0.32% | -846.5K | 2026-06-30 |
| UBS Group AG | 1.31M | $21.0M | 0.30% | +1.23M | 2026-06-30 |
| MORGAN STANLEY | 954.9K | $15.0M | 0.22% | +808.8K | 2026-06-30 |
| Logos Global Management LP | 915.0K | $15.0M | 0.21% | +890.0K | 2026-06-30 |
| Patient Square Capital LP | 909.5K | $14.0M | 0.21% | +215.9K | 2026-06-30 |
